Efficacy and safety of dual-targeted therapy for inflammatory bowel disease: a retrospective multicenter study in China
Background: Treatment options for patients with refractory inflammatory bowel disease (IBD) or concomitant IBD and extraintestinal manifestations (EIM) are often limited. Objective: This study aimed to examine the efficacy and safety of combining biologics or small molecules in patients with refract...
Saved in:
| Main Authors: | Xiuxiu Jin, Kefang Sun, Liying Wang, Haiyan Shen, Dan Ma, Tejia Shen, Chunxiao Chen, Lan Li |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2025-01-01
|
| Series: | Therapeutic Advances in Gastroenterology |
| Online Access: | https://doi.org/10.1177/17562848241307598 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and safety of dual-targeted therapy for refractory inflammatory bowel disease: a retrospective case series from three tertiary general hospitals in China
by: Xiaoying Wang, et al.
Published: (2025-05-01) -
Advancements in dual biologic therapy for inflammatory bowel diseases: efficacy, safety, and future directions
by: Adam Fabisiak, et al.
Published: (2025-01-01) -
Dual Therapy in Inflammatory Bowel Disease
by: Gabriele Altieri, et al.
Published: (2025-02-01) -
Editorial: The safety and efficacy of ustekinumab in anti-TNFα refractory pediatric inflammatory bowel disease
by: Katelynn K. Ho, et al.
Published: (2025-03-01) -
Multicenter retrospective comparison of safety and efficacy among three antithrombotic regimens following TAVI
by: Yu Ren, et al.
Published: (2025-06-01)